Pre-operative
Pre-discharge
1 to 3 months
Pre-operative to Pre-discharge; Pre- to 3-months
A. Severe LV dysfunction (LVEF < 35%) (N=18)
LV EF (%) 30 ± 4 29 ± 12 28 ± 12 p=0.63; p=0.25
LV EDVI (mL/m²) 102 ± 23 77 ± 17 90 ± 47 p<0.01; p=0.32
LV ESVI (mL/m²) 72 ± 18 54 ± 17 68 ± 42 p<0.01; p=0.76
LV global longitudinal strain (%) -9.4 ±3 -8.5 ± 3 -7.5 ± 6 p=0.24; p=0.15
LV circumferential strain (%) -12 ± 3 -16 ± 9 -14 ± 7 p=0.70; p=0.48
LV radial strain (%) 7 ± 3 7 ± 10 7 ± 12 p=1.0; p=0.30
Regurgitant orifice area (cm²) 0.52 ± 0.3 N/A N/A N/A
PASP (mmHg) 48 ± 14 39 ± 15 32 ± 9 p=0.09; p=0.01
RV FAC (%) 25 ± 9 33 ± 10 35 ± 11 p=0.02; p=0.03
RVFWLS (%) -13±5 -18 ± 8 -17±7 p=0.21; p=0.08
RVS’ 6.5±2.1 6.9±2.2 7.2±2.3 p=1.0; p=0.46
TAPSE (cm) 1.3±0.5 1.5±0.6 1.5±0.6 p=0.83; p=0.17